CAC Use in CV Risk Stratification: CorCal Outcomes

CAC Use in CV Risk Stratification: CorCal Out...

Up next

Remote Exercise SWEDEHEART: Cross-over Trial on Cardiac Telerehabilitation

Remote Exercise SWEDEHEART was designed to address persistently low participation in traditional cardiac rehabilitation following myocardial infarction. By delivering exercise-based rehabilitation remotely, the study aims to make recovery programs more accessible and convenient f ...  Show more

TRANQUILITY: IL-6, An Important Mediator of CVD

The TRANQUILITY trial was designed to evaluate whether pacibekitug can reduce interleukin-6 (IL-6)-driven inflammation, a key inflammatory pathway increasingly linked to cardiovascular risk. Treatment with pacibekitug demonstrated favorable effects on inflammatory and cardiovascu ...  Show more

Recommended Episodes

#132 Does PCI Save Lives in Heart Failure and CAD? Beyond Journal Club on the REVIVED Trial
Core IM | Internal Medicine Podcast

In patients with heart failure with low ejection fraction and chronic coronary disease without unstable symptoms, does stenting open blocked coronary arteries extend life or reduce hospitalizations? There is some literature to suggest those with low EF may benefit from revascular ...  Show more

Reframing Cardiovascular Care | JACC This Week
JACC This Week

In this episode, Dr. Harlan Krumholz introduces the September 16, 2025 issue of JACC, which features studies that challenge conventional clinical thinking, including a detailed ECMO physiology study showing that higher ECMO flow does not uniformly raise pulmonary capillary wedge ...  Show more

AI, Polygenic Risk Scores, and Antithrombotic Therapy | JACC This Week
JACC This Week

In this episode, Editor-in-Chief Harlan Krumholz explores the evolving landscape of cardiovascular medicine, beginning with a call for responsible stewardship of artificial intelligence. Highlights include a major registry study on percutaneous aspiration for right-sided endocard ...  Show more